Pros and Cons: RAAS blockers, SGLT-2 inhibitors, GLP-1-RA and ns-mineralcorticoid RA given at the same time?
19 May, 2024
0 Comments
1 category
Berlin – For decades, type 2 diabetes with chronic kidney disease (CKD) has been treated by controlling blood sugar and cardiovascular risk factors, with RAAS inhibitors (RAASi) being preferred to lower blood pressure. One try,…